Tracing the H3K36me2 Signal: CUT&RUN Enabled Insights into NSD2 Inhibitor Response
Interrupting the epigenetic programs that drive tumor growth is a promising avenue for cancer therapy, and NSD2 is emerging as […]
Interrupting the epigenetic programs that drive tumor growth is a promising avenue for cancer therapy, and NSD2 is emerging as […]